Skip to main content
Erschienen in: Endocrine 1/2019

24.09.2018 | Original Article

Adult individuals with congenital, untreated, severe isolated growth hormone deficiency have satisfactory muscular function

verfasst von: Alana L Andrade-Guimarães, Manuel H Aguiar-Oliveira, Roberto Salvatori, Vitor O. Carvalho, Fabiano Alvim-Pereira, Carlos R. Araújo Daniel, Giulliani A. Moreira Brasileiro, Ananda A Santana-Ribeiro, Hugo A. Santos-Carvalho, Carla R. P. Oliveira, Edgar R Vieira, Miburge B Gois-Junior

Erschienen in: Endocrine | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

While growth hormone (GH) and the insulin-like growth factor type I (IGF-I) are known to exert synergistic actions on muscle anabolism, the consequences of prolonged GH deficiency (GHD) on muscle function have not been well defined. We have previously described a large cohort of subjects with isolated GHD (IGHD) caused by a mutation in the GH-releasing hormone receptor gene, with low serum levels of GH and IGF-I. The aim of this study was to assess muscular function in these IGHD subjects.

Methods

A total of 31 GH-naïve IGHD (16 males) and 40 control (20 males) subjects, matched by age and degree of daily physical activity, were enrolled. Fat free mass was measured by bioelectrical impedance; muscle strength by dynamometry of handgrip, trunk extension, and knee extension; myoelectric activity and muscle fatigue by fractal dimension; conduction velocity in vastus medialis, rectus femoris, and vastus lateralis muscles by surface electromyography.

Results

The IGHD group showed higher knee extension strength both when corrected for weight and fat free mass, and higher handgrip and trunk extension strength corrected by fat free mass. They also exhibit higher conduction velocity of the muscles vastus medialis, rectus femoris, and vastus lateralis, but lower free fat mass and myoelectric activity of the vastus medialis, rectus femoris and vastus lateralis. There were no differences between the two groups in fractal dimension in all studied muscles.

Conclusion

Individuals with untreated IGHD have better muscle strength parameters adjusted for weight and fat free mass than controls. They also exhibit greater peripheral resistance to fatigue, demonstrating satisfactory muscle function.
Literatur
1.
Zurück zum Zitat J. Trezise, N. Collier, A.J. Blazevich, Anatomical and neuromuscular variables strongly predict maximum knee extension torque in healthy men. Eur. J. Appl. Physiol. 116, 1159–1177 (2016)CrossRefPubMed J. Trezise, N. Collier, A.J. Blazevich, Anatomical and neuromuscular variables strongly predict maximum knee extension torque in healthy men. Eur. J. Appl. Physiol. 116, 1159–1177 (2016)CrossRefPubMed
2.
Zurück zum Zitat T.S. Gross, S.L. Poliachik, J. Prasad, S.D. Bain, The effect of muscle dysfunction on bone mass and morphology. J. Musculoskelet. Neuron. Interact. 10, 25–34 (2010) T.S. Gross, S.L. Poliachik, J. Prasad, S.D. Bain, The effect of muscle dysfunction on bone mass and morphology. J. Musculoskelet. Neuron. Interact. 10, 25–34 (2010)
3.
Zurück zum Zitat J.B. Tyrovola, The ‘Mechanostat’ principle and the osteoprotegerin-OPG/RANKL/RANK system PART II. The role of the hypothalamic - pituitary axis. J. Cell. Biochem. 966, 1–20 (2016) J.B. Tyrovola, The ‘Mechanostat’ principle and the osteoprotegerin-OPG/RANKL/RANK system PART II. The role of the hypothalamic - pituitary axis. J. Cell. Biochem. 966, 1–20 (2016)
4.
Zurück zum Zitat Y.H. Song, J.L. Song, P. Delafontaine, M.P. Godard, The therapeutic potential of IGF-I in skeletal muscle repair. Trends Endocrinol. Metab. 24, 310–319 (2013)CrossRefPubMedPubMedCentral Y.H. Song, J.L. Song, P. Delafontaine, M.P. Godard, The therapeutic potential of IGF-I in skeletal muscle repair. Trends Endocrinol. Metab. 24, 310–319 (2013)CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat C.Q. Gao, R. Zhi, Z. Yang, H.C. Li, H.C. Yan, X.Q. Wang, Low dose of IGF-I increases cell size of skeletal muscle satellite cells via Akt/S6K signaling pathway. J. Cell. Biochem. 116, 2637–2648 (2015)CrossRefPubMed C.Q. Gao, R. Zhi, Z. Yang, H.C. Li, H.C. Yan, X.Q. Wang, Low dose of IGF-I increases cell size of skeletal muscle satellite cells via Akt/S6K signaling pathway. J. Cell. Biochem. 116, 2637–2648 (2015)CrossRefPubMed
6.
Zurück zum Zitat J.C. Chow, P.R. Ling, Z. Qu, L. Laviola, A. Ciccarone, B.R. Bistrian, R.J. Smith, Growth hormone stimulates tyrosine phosphorylation of JAK2 and STAT5, but not insulin receptor substrate-1 or SHC proteins in liver and skeletal muscle of normal rats in vivo. Endocrinology 137, 2880–2886 (1996)CrossRefPubMed J.C. Chow, P.R. Ling, Z. Qu, L. Laviola, A. Ciccarone, B.R. Bistrian, R.J. Smith, Growth hormone stimulates tyrosine phosphorylation of JAK2 and STAT5, but not insulin receptor substrate-1 or SHC proteins in liver and skeletal muscle of normal rats in vivo. Endocrinology 137, 2880–2886 (1996)CrossRefPubMed
7.
Zurück zum Zitat X. Ge, J. Yu, H. Jiang, Growth hormone stimulates protein synthesis in bovine skeletal muscle cells without altering insulin-like growth factor-I mRNA expression. J. Anim. Sci. 90, 1126–1133 (2012)CrossRefPubMed X. Ge, J. Yu, H. Jiang, Growth hormone stimulates protein synthesis in bovine skeletal muscle cells without altering insulin-like growth factor-I mRNA expression. J. Anim. Sci. 90, 1126–1133 (2012)CrossRefPubMed
8.
Zurück zum Zitat V. Chikani, K.K.Y. Ho, Action of GH on skeletal muscle function: molecular and metabolic mechanisms. J. Mol. Endocrinol. 52, 107–123 (2013)CrossRef V. Chikani, K.K.Y. Ho, Action of GH on skeletal muscle function: molecular and metabolic mechanisms. J. Mol. Endocrinol. 52, 107–123 (2013)CrossRef
9.
10.
Zurück zum Zitat D.D. Bikle, C. Tahimic, W. Chang, Y. Wang, A. Philippou, E.R. Barton, Role of IGF-I signaling in muscle bone interactions. Bone 80, 79–88 (2015)CrossRefPubMedPubMedCentral D.D. Bikle, C. Tahimic, W. Chang, Y. Wang, A. Philippou, E.R. Barton, Role of IGF-I signaling in muscle bone interactions. Bone 80, 79–88 (2015)CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat D.S. Kim, E. Itoh, K. Iida, M.O. Thorner, Growth hormone icreases mRNA Levels of PPAR δ and Foxo1 in skeletal muscle of growth hormone deficient lit / lit mice. Endocr. J. 56, 141–147 (2009)CrossRefPubMed D.S. Kim, E. Itoh, K. Iida, M.O. Thorner, Growth hormone icreases mRNA Levels of PPAR δ and Foxo1 in skeletal muscle of growth hormone deficient lit / lit mice. Endocr. J. 56, 141–147 (2009)CrossRefPubMed
12.
Zurück zum Zitat E.O. List, L. Sackmann-Sala, D.E. Berryman, K. Funk, B. Kelder, E.S. Gosney, S. Okada, J. Ding, D. Cruz-Topete, J.J. Kopchick, Endocrine parameters and phenotypes of the growth hormone receptor gene disrupted (GHR−/−) mouse. Endocr. Rev. 32, 356–386 (2011)CrossRefPubMed E.O. List, L. Sackmann-Sala, D.E. Berryman, K. Funk, B. Kelder, E.S. Gosney, S. Okada, J. Ding, D. Cruz-Topete, J.J. Kopchick, Endocrine parameters and phenotypes of the growth hormone receptor gene disrupted (GHR−/−) mouse. Endocr. Rev. 32, 356–386 (2011)CrossRefPubMed
13.
Zurück zum Zitat K.T. Coschigano, A.N. Holland, M.E. Riders, E.O. List, A. Flyvbjerg, J.J. Kopchick, Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span. Endocrinology 144, 3799–3810 (2003)CrossRefPubMed K.T. Coschigano, A.N. Holland, M.E. Riders, E.O. List, A. Flyvbjerg, J.J. Kopchick, Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span. Endocrinology 144, 3799–3810 (2003)CrossRefPubMed
14.
Zurück zum Zitat R. Basu, Y. Qian, J.J. Kopchick, Mechanisms in endocrinology: lessons from growth hormone receptor gene disrupted mice: are there benefits of endocrine defects? Eur. J. Endocrinol. 181, 155–181 (2018)CrossRef R. Basu, Y. Qian, J.J. Kopchick, Mechanisms in endocrinology: lessons from growth hormone receptor gene disrupted mice: are there benefits of endocrine defects? Eur. J. Endocrinol. 181, 155–181 (2018)CrossRef
15.
Zurück zum Zitat S. Shibata, C. Ueno, T. Ito, K. Yamanouchi, T. Matsuwaki, M. Nishihara, Skeletal muscle growth defect in human growth hormone transgenic rat is accompanied by phenotypic changes in progenitor cells. Age 32, 239–253 (2010)CrossRefPubMedPubMedCentral S. Shibata, C. Ueno, T. Ito, K. Yamanouchi, T. Matsuwaki, M. Nishihara, Skeletal muscle growth defect in human growth hormone transgenic rat is accompanied by phenotypic changes in progenitor cells. Age 32, 239–253 (2010)CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat N. Improda, D. Capalbo, A. Esposito, M. Salerno, Muscle and skeletal health in children and adolescents with GH deficiency. Best. Pract. Res. Clin. Endocrinol. Metab. 30, 771–783 (2016)CrossRefPubMed N. Improda, D. Capalbo, A. Esposito, M. Salerno, Muscle and skeletal health in children and adolescents with GH deficiency. Best. Pract. Res. Clin. Endocrinol. Metab. 30, 771–783 (2016)CrossRefPubMed
17.
Zurück zum Zitat L.J. Woodhouse, A. Mukherjee, S.M. Shalet, S. Ezzat, The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults. Endocr. Rev. 27, 287–317 (2006)CrossRefPubMed L.J. Woodhouse, A. Mukherjee, S.M. Shalet, S. Ezzat, The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults. Endocr. Rev. 27, 287–317 (2006)CrossRefPubMed
18.
Zurück zum Zitat A. Sartorio, F. Agosti, A.D. Col, G. Mazzilli, N. Marazzi, C. Busti, R. Galli, C.L. Lafortuna, Muscle strength and power, maximum oxygen consumption, and body composition in middle-aged short-stature adults with childhood-onset growth harmone deficiency. Arch. Med. Res. 39, 78–83 (2008)CrossRefPubMed A. Sartorio, F. Agosti, A.D. Col, G. Mazzilli, N. Marazzi, C. Busti, R. Galli, C.L. Lafortuna, Muscle strength and power, maximum oxygen consumption, and body composition in middle-aged short-stature adults with childhood-onset growth harmone deficiency. Arch. Med. Res. 39, 78–83 (2008)CrossRefPubMed
19.
Zurück zum Zitat W.M. Widdowson, J. Gibney, The effect of growth hormone (GH) replacement on muscle strength in patients with GH-deficiency: A meta-analysis. Clin. Endocrinol. (Oxf.). 72, 787–792 (2010)CrossRefPubMed W.M. Widdowson, J. Gibney, The effect of growth hormone (GH) replacement on muscle strength in patients with GH-deficiency: A meta-analysis. Clin. Endocrinol. (Oxf.). 72, 787–792 (2010)CrossRefPubMed
20.
Zurück zum Zitat M.J. Modesto, N.M. Amer, O. Erichsen, S. Hernandez, C.D. Santos, J.A.R. Carvalho, R.M. Pereira, S.N. França, L. Lacerda, Muscle strength and body composition during the transition phase in patients treated with recombinant GH to final height. J. Pediatr. Endocrinol. Metab. 27, 813–820 (2014) M.J. Modesto, N.M. Amer, O. Erichsen, S. Hernandez, C.D. Santos, J.A.R. Carvalho, R.M. Pereira, S.N. França, L. Lacerda, Muscle strength and body composition during the transition phase in patients treated with recombinant GH to final height. J. Pediatr. Endocrinol. Metab. 27, 813–820 (2014)
21.
Zurück zum Zitat K. Hermansen, M. Bengtsen, M. Kjær, P. Vestergaard, J.O.L. Jørgensen, Impact of GH administration on athletic performance in healthy young adults: a systematic review and meta-analysis of placebo-controlled trials. Growth Horm. IGF Res. 34, 38–44 (2017)CrossRefPubMed K. Hermansen, M. Bengtsen, M. Kjær, P. Vestergaard, J.O.L. Jørgensen, Impact of GH administration on athletic performance in healthy young adults: a systematic review and meta-analysis of placebo-controlled trials. Growth Horm. IGF Res. 34, 38–44 (2017)CrossRefPubMed
22.
Zurück zum Zitat R. Salvatori, C.Y. Hayashida, M.H. Aguiar-Oliveira, J.A. Phillips, A.H.O. Souza, R.G. Gondo, S.P.A. Toledo, M.M. Conceicão, M. Prince, H.G. Maheshwari, G. Baumann, M.A. Levine, Familial dwarfism due to a novel mutation of the growth hormone-releasing hormone receptor gene. J. Clin. Endocrinol. Metab. 84, 917–923 (1999)PubMed R. Salvatori, C.Y. Hayashida, M.H. Aguiar-Oliveira, J.A. Phillips, A.H.O. Souza, R.G. Gondo, S.P.A. Toledo, M.M. Conceicão, M. Prince, H.G. Maheshwari, G. Baumann, M.A. Levine, Familial dwarfism due to a novel mutation of the growth hormone-releasing hormone receptor gene. J. Clin. Endocrinol. Metab. 84, 917–923 (1999)PubMed
23.
Zurück zum Zitat M.H. Aguiar-Oliveira, M.S. Gill, F. Miraki-Moud, C.A. Menezes, A.H.O. Souza, C.E. Martinelli, F.A. Pereira, R. Salvatori, M.A. Levine, S.M. Shalet, C. Camacho-Hubner, P.E. Clayton, Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on Insulin-Like Growth Factors (IGFs), IGF-Binding Proteins, and Ternary Complex Formation Throughout Life. J. Clin. Endocrinol. Metab. 84, 4118–4126 (1999)PubMed M.H. Aguiar-Oliveira, M.S. Gill, F. Miraki-Moud, C.A. Menezes, A.H.O. Souza, C.E. Martinelli, F.A. Pereira, R. Salvatori, M.A. Levine, S.M. Shalet, C. Camacho-Hubner, P.E. Clayton, Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on Insulin-Like Growth Factors (IGFs), IGF-Binding Proteins, and Ternary Complex Formation Throughout Life. J. Clin. Endocrinol. Metab. 84, 4118–4126 (1999)PubMed
24.
Zurück zum Zitat M.H. Aguiar-Oliveira, A.H.O. Souza, C.R.P. Oliveira, V.C. Campos, L.A. Oliveira-Neto, R. Salvatori, The multiple facets of GHRH/GH/IGF-I axis: lessons from lifetime, untreated, isolated GH deficiency due to a GHRH receptor gene mutation. Eur. J. Endocrinol. 177, 85–97 (2017)CrossRef M.H. Aguiar-Oliveira, A.H.O. Souza, C.R.P. Oliveira, V.C. Campos, L.A. Oliveira-Neto, R. Salvatori, The multiple facets of GHRH/GH/IGF-I axis: lessons from lifetime, untreated, isolated GH deficiency due to a GHRH receptor gene mutation. Eur. J. Endocrinol. 177, 85–97 (2017)CrossRef
25.
Zurück zum Zitat M.B. Gois-Junior, R. Salvatori, M.H. Aguiar-Oliveira, F.A. Pereira, C.R.P. Oliveira, L.A. Oliveira-Neto, R.M.C. Pereira, A.H.O. Souza, E.V. Melo, F.J.A. Paula, The consequences of growth hormone-releasing hormone receptor haploinsufficiency for bone quality and insulin resistance. Clin. Endocrinol. (Oxf.). 77, 379–384 (2012)CrossRef M.B. Gois-Junior, R. Salvatori, M.H. Aguiar-Oliveira, F.A. Pereira, C.R.P. Oliveira, L.A. Oliveira-Neto, R.M.C. Pereira, A.H.O. Souza, E.V. Melo, F.J.A. Paula, The consequences of growth hormone-releasing hormone receptor haploinsufficiency for bone quality and insulin resistance. Clin. Endocrinol. (Oxf.). 77, 379–384 (2012)CrossRef
26.
Zurück zum Zitat C.C. Epitácio-Pereira, G.M.F. Silva, R. Salvatori, J.A.M. Santana, F.A. Pereira, M.B. Gois-Junior, A.V.O. Britto, C.R.P. Oliveira, A.H.O. Souza, E.G. Santos, V.C. Campos, R.M.C. Pereira, E.H.O. Valença, R.A.A. Barbosa, M.I.T. Farias, F.J.A. Paula, T.V. Ribeiro, M.C.P. Oliveira, M.H. Aguiar-Oliveira, Isolated GH deficiency due to a GHRH receptor mutation causes hip joint problems and genu valgum, and reduces size but not density of trabecular and mixed bone. J. Clin. Endocrinol. Metab. 98, 1710–1715 (2013)CrossRef C.C. Epitácio-Pereira, G.M.F. Silva, R. Salvatori, J.A.M. Santana, F.A. Pereira, M.B. Gois-Junior, A.V.O. Britto, C.R.P. Oliveira, A.H.O. Souza, E.G. Santos, V.C. Campos, R.M.C. Pereira, E.H.O. Valença, R.A.A. Barbosa, M.I.T. Farias, F.J.A. Paula, T.V. Ribeiro, M.C.P. Oliveira, M.H. Aguiar-Oliveira, Isolated GH deficiency due to a GHRH receptor mutation causes hip joint problems and genu valgum, and reduces size but not density of trabecular and mixed bone. J. Clin. Endocrinol. Metab. 98, 1710–1715 (2013)CrossRef
27.
Zurück zum Zitat J.A.R. Barbosa, R. Salvatori, C.R.P. Oliveira, R.M.C. Pereira, C.T. Farias, A.V.O. Britto, N.T. Farias, A. Blackford, M.H. Aguiar-Oliveira, Quality of life in congenital, untreated, lifetime isolated growth hormone deficiency. Psychoneuroendocrinology 34, 894–900 (2009)CrossRefPubMed J.A.R. Barbosa, R. Salvatori, C.R.P. Oliveira, R.M.C. Pereira, C.T. Farias, A.V.O. Britto, N.T. Farias, A. Blackford, M.H. Aguiar-Oliveira, Quality of life in congenital, untreated, lifetime isolated growth hormone deficiency. Psychoneuroendocrinology 34, 894–900 (2009)CrossRefPubMed
28.
Zurück zum Zitat M.H. Aguiar-Oliveira, F.T. Oliveira, R.M.C. Pereira, C.R.P. Oliveira, A. Blackford, E.H.O. Valenca, E.G. Santos, M.B. Gois-Junior, R.A. Meneguz-Moreno, V.P. Araujo, L.A. Oliveira-Neto, R.P. Almeida, M.A. Santos, N.T. Farias, D.C.R. Silveira, G.W. Cabral, F.R. Calazans, J.D. Seabra, T.F. Lopes, E.O. Rodrigues, L.A. Porto, I.P. Oliveira, E.V. Melo, M. Martari, R. Salvatori, Longevity in untreated congenital growth hormone deficiency due to a homozygous mutation in the GHRH receptor gene. J. Clin. Endocrinol. Metab. 95, 714–721 (2010)CrossRefPubMed M.H. Aguiar-Oliveira, F.T. Oliveira, R.M.C. Pereira, C.R.P. Oliveira, A. Blackford, E.H.O. Valenca, E.G. Santos, M.B. Gois-Junior, R.A. Meneguz-Moreno, V.P. Araujo, L.A. Oliveira-Neto, R.P. Almeida, M.A. Santos, N.T. Farias, D.C.R. Silveira, G.W. Cabral, F.R. Calazans, J.D. Seabra, T.F. Lopes, E.O. Rodrigues, L.A. Porto, I.P. Oliveira, E.V. Melo, M. Martari, R. Salvatori, Longevity in untreated congenital growth hormone deficiency due to a homozygous mutation in the GHRH receptor gene. J. Clin. Endocrinol. Metab. 95, 714–721 (2010)CrossRefPubMed
29.
Zurück zum Zitat World Health Organization - Measuring obesity: classification, and description of anthropometric data. Copenhagen: World Health Organization. 1988. World Health Organization - Measuring obesity: classification, and description of anthropometric data. Copenhagen: World Health Organization. 1988.
30.
Zurück zum Zitat IPAQ Research Committee. Guidelines for data processing and analysis of the international physical activity questionnaire (IPAQ) short and long forms. In: International physical activity questionnaire (2005) IPAQ Research Committee. Guidelines for data processing and analysis of the international physical activity questionnaire (IPAQ) short and long forms. In: International physical activity questionnaire (2005)
31.
Zurück zum Zitat J.R. Moon, J.R. Stout, A.E. Smith-Ryan, K.L. Kendall, D.H. Fukuda, J.T. Cramer, S.E. Moon, Tracking fat-free mass changes in elderly men and women using single-frequency bioimpedance and dual-energy X-ray absorptiometry: a four-compartment model comparison. Eur. J. Clin. Nutr. 67, 40–46 (2013)CrossRef J.R. Moon, J.R. Stout, A.E. Smith-Ryan, K.L. Kendall, D.H. Fukuda, J.T. Cramer, S.E. Moon, Tracking fat-free mass changes in elderly men and women using single-frequency bioimpedance and dual-energy X-ray absorptiometry: a four-compartment model comparison. Eur. J. Clin. Nutr. 67, 40–46 (2013)CrossRef
32.
Zurück zum Zitat U.G. Kyle, I. Bosaeus, A.D. Lorenzo, P. Deurenberg, M. Elia, J.M. Gómez, B.L. Heitmann, L. Kent-Smith, J.C. Melchior, M. Pirlich, H. Scharfetter, A.M.W.J. Schols, C. Pichard, Bioelectrical impedance analysis - Part I: review of principles and methods. Clin. Nutr. 23, 1226–1243 (2004)CrossRefPubMed U.G. Kyle, I. Bosaeus, A.D. Lorenzo, P. Deurenberg, M. Elia, J.M. Gómez, B.L. Heitmann, L. Kent-Smith, J.C. Melchior, M. Pirlich, H. Scharfetter, A.M.W.J. Schols, C. Pichard, Bioelectrical impedance analysis - Part I: review of principles and methods. Clin. Nutr. 23, 1226–1243 (2004)CrossRefPubMed
33.
Zurück zum Zitat G. Sergi, M. Rui, B. Stubbs, N. Veronese, E. Manzato, Measurement of lean body mass using bioelectrical impedance analysis: a consideration of the pros and cons. Aging Clin. Exp. Res. 29, 591–597 (2017)CrossRefPubMed G. Sergi, M. Rui, B. Stubbs, N. Veronese, E. Manzato, Measurement of lean body mass using bioelectrical impedance analysis: a consideration of the pros and cons. Aging Clin. Exp. Res. 29, 591–597 (2017)CrossRefPubMed
34.
Zurück zum Zitat S.R. Silva, T.H. Nakagawa, A.L.G. Ferreira, L.C. Garcia, J.E.M. Santos, F.V. Serrão, Lower limb strength and flexibility in athletes with and without patellar tendinopathy. Phys. Ther. Sport. 20, 19–25 (2016)CrossRef S.R. Silva, T.H. Nakagawa, A.L.G. Ferreira, L.C. Garcia, J.E.M. Santos, F.V. Serrão, Lower limb strength and flexibility in athletes with and without patellar tendinopathy. Phys. Ther. Sport. 20, 19–25 (2016)CrossRef
35.
Zurück zum Zitat Fess E.: Grip strength. Clinical assessment recommendations. American Society of Hand Therapists. 41–45. Chicago (1992) Fess E.: Grip strength. Clinical assessment recommendations. American Society of Hand Therapists. 41–45. Chicago (1992)
36.
Zurück zum Zitat F.L.F. Eichinger, A.V. Soares, J.M. Carvalho, M.S. Gevaerd, S.C. Domenech, N.G. Borges, Dinamometria lombar: Um teste funcional para o tronco. Rev. Bras. Med Trab. 14, 120–126 (2016)CrossRef F.L.F. Eichinger, A.V. Soares, J.M. Carvalho, M.S. Gevaerd, S.C. Domenech, N.G. Borges, Dinamometria lombar: Um teste funcional para o tronco. Rev. Bras. Med Trab. 14, 120–126 (2016)CrossRef
37.
Zurück zum Zitat S. Dorsch, L. Ada, C.G. Canning, Lower limb strength is significantly impaired in all muscle groups in ambulatory people with chronic stroke: a cross-sectional study. Arch. Phys. Med. Rehabil. 97, 522–527 (2016)CrossRefPubMed S. Dorsch, L. Ada, C.G. Canning, Lower limb strength is significantly impaired in all muscle groups in ambulatory people with chronic stroke: a cross-sectional study. Arch. Phys. Med. Rehabil. 97, 522–527 (2016)CrossRefPubMed
38.
Zurück zum Zitat U. Grevstad, P. Jæger, J.K. Sørensen, B. Gottschau, B. Ilfeld, M. Ballegaard, M. Hagelskjaer, J.B. Dahl, The effect of local anesthetic volume within the adductor canal on quadriceps femoris function evaluated by electromyography: a randomized, observer- and infject-blinded, placebo-controlled study in volunteers. Anesth. Analg. 123, 493–500 (2016)CrossRefPubMed U. Grevstad, P. Jæger, J.K. Sørensen, B. Gottschau, B. Ilfeld, M. Ballegaard, M. Hagelskjaer, J.B. Dahl, The effect of local anesthetic volume within the adductor canal on quadriceps femoris function evaluated by electromyography: a randomized, observer- and infject-blinded, placebo-controlled study in volunteers. Anesth. Analg. 123, 493–500 (2016)CrossRefPubMed
39.
Zurück zum Zitat H.J. Hermens, B. Freriks, C. Disselhorst-Klug, G. Rau, Development of recommendations for SEMG sensors and sensor placement procedures. J. Electromyogr. Kinesiol. 10, 361–374 (2000)CrossRefPubMed H.J. Hermens, B. Freriks, C. Disselhorst-Klug, G. Rau, Development of recommendations for SEMG sensors and sensor placement procedures. J. Electromyogr. Kinesiol. 10, 361–374 (2000)CrossRefPubMed
40.
Zurück zum Zitat D.M. Pincivero, R.C. Green, J.D. Mark, R.M. Campy, Gender and muscle differences in EMG amplitude and median frequency, and variability during maximal voluntary contractions of the quadriceps femoris. J. Electromyogr. Kinesiol. 10, 189–196 (2000)CrossRefPubMed D.M. Pincivero, R.C. Green, J.D. Mark, R.M. Campy, Gender and muscle differences in EMG amplitude and median frequency, and variability during maximal voluntary contractions of the quadriceps femoris. J. Electromyogr. Kinesiol. 10, 189–196 (2000)CrossRefPubMed
41.
Zurück zum Zitat E.C. Conchola, R.M. Thiele, T.B. Palmer, D.B. Smith, B.J. Thompson, Effects of neuromuscular fatigue on electromechanical delay of the leg extensors and flexors in young men and women. Muscle Nerve 52, 844–851 (2015)CrossRefPubMed E.C. Conchola, R.M. Thiele, T.B. Palmer, D.B. Smith, B.J. Thompson, Effects of neuromuscular fatigue on electromechanical delay of the leg extensors and flexors in young men and women. Muscle Nerve 52, 844–851 (2015)CrossRefPubMed
42.
Zurück zum Zitat M.W. Buckthorpe, R. Hannah, T.G. Pain, J.P. Folland, Reliability of neuromuscular measurements during explosive isometric contractions, with special reference to electromyography normalization techniques. Muscle Nerve 46, 566–576 (2012)CrossRefPubMed M.W. Buckthorpe, R. Hannah, T.G. Pain, J.P. Folland, Reliability of neuromuscular measurements during explosive isometric contractions, with special reference to electromyography normalization techniques. Muscle Nerve 46, 566–576 (2012)CrossRefPubMed
43.
Zurück zum Zitat M. Beretta-Piccoli, G. D’Antona, M. Barbero, B. Fisher, C.M. Dieli-Conwright, R. Clijsen, C. Cescon, Evaluation of central and peripheral fatigue in the quadriceps using fractal dimension and conduction velocity in young females. PLoS. One. 10, 1–15 (2015)CrossRef M. Beretta-Piccoli, G. D’Antona, M. Barbero, B. Fisher, C.M. Dieli-Conwright, R. Clijsen, C. Cescon, Evaluation of central and peripheral fatigue in the quadriceps using fractal dimension and conduction velocity in young females. PLoS. One. 10, 1–15 (2015)CrossRef
44.
Zurück zum Zitat E. Hohenauer, C. Cescon, T. Deliens, P. Clarys, R. Clijsen, The effect of local skin cooling before a sustained, submaximal isometric contraction on fatigue and isometric quadriceps femoris performance: a randomized controlled trial. J. Therm. Biol. 65, 88–94 (2017)CrossRefPubMed E. Hohenauer, C. Cescon, T. Deliens, P. Clarys, R. Clijsen, The effect of local skin cooling before a sustained, submaximal isometric contraction on fatigue and isometric quadriceps femoris performance: a randomized controlled trial. J. Therm. Biol. 65, 88–94 (2017)CrossRefPubMed
45.
Zurück zum Zitat J.A.S. Barreto-Filho, M.R.S. Alcantara, R. Salvatori, M.A. Barreto, A.C.S. Sousa, V. Bastos, A.H. Souza, R.M.C. Pereira, P.E. Clayton, M.S. Gill, M.H. Aguiar-Oliveira, Familial isolated growth hormone deficiency is associated with increased systolic blood pressure, central obesity and dyslipidemia. J. Clin. Endocrinol. Metab. 87, 2018–2023 (2002)CrossRefPubMed J.A.S. Barreto-Filho, M.R.S. Alcantara, R. Salvatori, M.A. Barreto, A.C.S. Sousa, V. Bastos, A.H. Souza, R.M.C. Pereira, P.E. Clayton, M.S. Gill, M.H. Aguiar-Oliveira, Familial isolated growth hormone deficiency is associated with increased systolic blood pressure, central obesity and dyslipidemia. J. Clin. Endocrinol. Metab. 87, 2018–2023 (2002)CrossRefPubMed
46.
Zurück zum Zitat R.C. Cuneo, F. Salomon, M. Wiles, P.H. Sönksen, Skeletal muscle performance in adults with growth hormone deficiency. Horm. Res. 33, 55–60 (1990)CrossRefPubMed R.C. Cuneo, F. Salomon, M. Wiles, P.H. Sönksen, Skeletal muscle performance in adults with growth hormone deficiency. Horm. Res. 33, 55–60 (1990)CrossRefPubMed
47.
Zurück zum Zitat A.R. Hoffman, J.E. Kuntze, J. Baptista, H.B.A. Baum, G.P. Baumann, B.M.K. Biller, R.V. Clark, D. Cook, S.E. Inzucchi, D. Kleinberg, A. Klibanski, L.S. Phillips, E.C. Ridgway, R.J. Robbins, J. Schlechte, M. Sharma, M.O. Thorner, M.L. Vance, Growth hormone (GH) replacement therapy in adult-onset gh deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial. J. Clin. Endocrinol. Metab. 89, 2048–2056 (2004)CrossRefPubMed A.R. Hoffman, J.E. Kuntze, J. Baptista, H.B.A. Baum, G.P. Baumann, B.M.K. Biller, R.V. Clark, D. Cook, S.E. Inzucchi, D. Kleinberg, A. Klibanski, L.S. Phillips, E.C. Ridgway, R.J. Robbins, J. Schlechte, M. Sharma, M.O. Thorner, M.L. Vance, Growth hormone (GH) replacement therapy in adult-onset gh deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial. J. Clin. Endocrinol. Metab. 89, 2048–2056 (2004)CrossRefPubMed
48.
Zurück zum Zitat S. Gonzalez, T. Sathyapalan, Z. Javed, S.L. Atkin, Effects of growth hormone replacement on peripheral muscle and exercise capacity in severe growth hormone deficiency. Front Endocrinol. (Lausanne). 8, 1–7 (2018) S. Gonzalez, T. Sathyapalan, Z. Javed, S.L. Atkin, Effects of growth hormone replacement on peripheral muscle and exercise capacity in severe growth hormone deficiency. Front Endocrinol. (Lausanne). 8, 1–7 (2018)
49.
Zurück zum Zitat G. Gotherstrom, M. Elbornsson, K. Stibrant-Sunnerhagen, B.A. Bengtsson, G. Johannsson, J. Svensson, Muscle strength in elderly adults with GH deficiency after 10 years of GH replacement. Eur. J. Endocrinol. 163, 207–215 (2010)CrossRefPubMed G. Gotherstrom, M. Elbornsson, K. Stibrant-Sunnerhagen, B.A. Bengtsson, G. Johannsson, J. Svensson, Muscle strength in elderly adults with GH deficiency after 10 years of GH replacement. Eur. J. Endocrinol. 163, 207–215 (2010)CrossRefPubMed
50.
Zurück zum Zitat W.M. Widdowson, J. Gibney, The effect of growth hormone replacement on exercise capacity in patients with GH deficiency: a metaanalysis. J. Clin. Endocrinol. Metab. 93, 4413–4417 (2008)CrossRefPubMed W.M. Widdowson, J. Gibney, The effect of growth hormone replacement on exercise capacity in patients with GH deficiency: a metaanalysis. J. Clin. Endocrinol. Metab. 93, 4413–4417 (2008)CrossRefPubMed
51.
Zurück zum Zitat R. Borde, T. Hortobágyi, U. Granacher, Dose–response relationships of resistance training in healthy old adults: a systematic review and meta-analysis. Sports Med. 45, 1693–1720 (2015)CrossRefPubMedPubMedCentral R. Borde, T. Hortobágyi, U. Granacher, Dose–response relationships of resistance training in healthy old adults: a systematic review and meta-analysis. Sports Med. 45, 1693–1720 (2015)CrossRefPubMedPubMedCentral
52.
Zurück zum Zitat T.M. Manini, B.C. Clark, Dynapenia and aging: an update. J. Gerontol. A. Biol. Sci. Med. Sci. 67, 28–40 (2012)CrossRefPubMed T.M. Manini, B.C. Clark, Dynapenia and aging: an update. J. Gerontol. A. Biol. Sci. Med. Sci. 67, 28–40 (2012)CrossRefPubMed
53.
Zurück zum Zitat García-Hermoso A., Cavero-Redondo I., Ramírez-Vélez R., Ruiz J. R., Ortega F. B., Lee D. C., Martínez-Vizcaíno V.: Muscular strength as a predictor of all-cause mortality in an apparently healthy population: a systematic review and meta-analysis of data from approximately 2 million men and women. Arch Phys Med Rehabil. https://doi.org/10.1016/j.apmr.2018.01.008 García-Hermoso A., Cavero-Redondo I., Ramírez-Vélez R., Ruiz J. R., Ortega F. B., Lee D. C., Martínez-Vizcaíno V.: Muscular strength as a predictor of all-cause mortality in an apparently healthy population: a systematic review and meta-analysis of data from approximately 2 million men and women. Arch Phys Med Rehabil. https://​doi.​org/​10.​1016/​j.​apmr.​2018.​01.​008
54.
Zurück zum Zitat I.C. Van-Nieuwpoort, M.C. Vlot, L.A. Schaap, P. Lips, M.L. Drent, The relationship between serum IGF-1, handgrip strength, physical performance and falls in elderly men and women. Eur. J. Endocrinol. 179, 73–84 (2018)CrossRefPubMed I.C. Van-Nieuwpoort, M.C. Vlot, L.A. Schaap, P. Lips, M.L. Drent, The relationship between serum IGF-1, handgrip strength, physical performance and falls in elderly men and women. Eur. J. Endocrinol. 179, 73–84 (2018)CrossRefPubMed
55.
Zurück zum Zitat M.V. Narici, H. Hoppeler, B. Kayser, L. Landoni, H. Claassen, C. Gavardi, M. Conti, P. Cerretelli, Human quadriceps cross-sectional area, torque and neural activation during 6 months strength training. Acta Physiol. Scand. 157, 175–186 (1996)CrossRefPubMed M.V. Narici, H. Hoppeler, B. Kayser, L. Landoni, H. Claassen, C. Gavardi, M. Conti, P. Cerretelli, Human quadriceps cross-sectional area, torque and neural activation during 6 months strength training. Acta Physiol. Scand. 157, 175–186 (1996)CrossRefPubMed
56.
Zurück zum Zitat C.J. Luca, The use of surface electromyography in biomechanics. J. Appl. Bio. 13, 135–163 (1997) C.J. Luca, The use of surface electromyography in biomechanics. J. Appl. Bio. 13, 135–163 (1997)
57.
Zurück zum Zitat A. Sinha, K.G. Hollingsworth, S. Ball, T. Cheetham, Impaired quality of life in growth hormone-deficient adults is independent of the altered skeletal muscle oxidative metabolism found in conditions with peripheral fatigue. Clin. Endocrinol. (Oxf.). 80, 107–114 (2014)CrossRefPubMed A. Sinha, K.G. Hollingsworth, S. Ball, T. Cheetham, Impaired quality of life in growth hormone-deficient adults is independent of the altered skeletal muscle oxidative metabolism found in conditions with peripheral fatigue. Clin. Endocrinol. (Oxf.). 80, 107–114 (2014)CrossRefPubMed
58.
Zurück zum Zitat E. Shurka, Z. Laron, Adjustment and rehabilitation problems of children and adolescents with growth retardation. I. Familial dwarfism with high plasma immunoreactive human growth hormone. Isr. J. Med. Sci. 11, 352–357 (1975)PubMed E. Shurka, Z. Laron, Adjustment and rehabilitation problems of children and adolescents with growth retardation. I. Familial dwarfism with high plasma immunoreactive human growth hormone. Isr. J. Med. Sci. 11, 352–357 (1975)PubMed
59.
Zurück zum Zitat Laron Z.: Muscle force and endurance in untreated adult and IGF-I treated children with laron syndrome. In Iaron syndrome - from man to mouse, pp. 161–164. Springer Berlin Heidelberg (2011) Laron Z.: Muscle force and endurance in untreated adult and IGF-I treated children with laron syndrome. In Iaron syndrome - from man to mouse, pp. 161–164. Springer Berlin Heidelberg (2011)
60.
Zurück zum Zitat S. Leone, A. Chiavaroli, R. Shohreh, C. Ferrante, A. Ricciuti, F. Manippa, L. Recinella, C.D. Nisio, G. Orlando, R. Salvatori, M. Vacca, L. Brunetti, Increased locomotor and thermogenic activity in mice with targeted ablation of the GHRH gene. Growth Horm. IGF Res. 25, 80–84 (2015)CrossRefPubMed S. Leone, A. Chiavaroli, R. Shohreh, C. Ferrante, A. Ricciuti, F. Manippa, L. Recinella, C.D. Nisio, G. Orlando, R. Salvatori, M. Vacca, L. Brunetti, Increased locomotor and thermogenic activity in mice with targeted ablation of the GHRH gene. Growth Horm. IGF Res. 25, 80–84 (2015)CrossRefPubMed
Metadaten
Titel
Adult individuals with congenital, untreated, severe isolated growth hormone deficiency have satisfactory muscular function
verfasst von
Alana L Andrade-Guimarães
Manuel H Aguiar-Oliveira
Roberto Salvatori
Vitor O. Carvalho
Fabiano Alvim-Pereira
Carlos R. Araújo Daniel
Giulliani A. Moreira Brasileiro
Ananda A Santana-Ribeiro
Hugo A. Santos-Carvalho
Carla R. P. Oliveira
Edgar R Vieira
Miburge B Gois-Junior
Publikationsdatum
24.09.2018
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 1/2019
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-018-1763-5

Weitere Artikel der Ausgabe 1/2019

Endocrine 1/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.